TABLE 1.
Treatment | Beat frequency | n |
---|---|---|
Hz | ||
None | 3.45 ± 0.19a | 97 |
DMSO (1%) | 3.27 ± 0.17a | 59 |
Adenosine analog | ||
Cl-dAdo (25 μm) | 6.32 ± 0.51d | 71 |
A1R agonist | ||
CCPA (100 μm) | 3.65 ± 0.18a | 62 |
A2R agonist | ||
CGS21680 (40 μm) | 2.50 ± 0.14b | 20 |
A3R agonist | ||
IB-MECA (100 μm) | 5.06 ± 0.37c | 53 |
Cl-IB-MECA (30 μm) | 5.87 ± 0.53c,d | 42 |
a These groups did not differ (p > 0.05).
b–d These groups differed from a and from one another (p < 0.05).